Follow
Shirin Tavakoli
Shirin Tavakoli
Verified email at helsinki.fi
Title
Cited by
Cited by
Year
Exploring the impact of morphology on the properties of biodegradable nanoparticles and their diffusion in complex biological medium
R Ridolfo, S Tavakoli, V Junnuthula, DS Williams, A Urtti, JCM van Hest
Biomacromolecules 22 (1), 126-133, 2020
1012020
Ocular barriers to retinal delivery of intravitreal liposomes: Impact of vitreoretinal interface
S Tavakoli, K Peynshaert, T Lajunen, J Devoldere, EM Del Amo, ...
Journal of controlled release 328, 952-961, 2020
552020
Diffusion and protein corona formation of lipid-based nanoparticles in the vitreous humor: profiling and pharmacokinetic considerations
S Tavakoli, OK Kari, T Turunen, T Lajunen, M Schmitt, J Lehtinen, ...
Molecular pharmaceutics 18 (2), 699-713, 2020
432020
Light-activated liposomes coated with hyaluronic acid as a potential drug delivery system
OK Kari, S Tavakoli, P Parkkila, S Baan, R Savolainen, T Ruoslahti, ...
Pharmaceutics 12 (8), 763, 2020
332020
Intravitreal polymeric nanocarriers with long ocular retention and targeted delivery to the retina and optic nerve head region
V Junnuthula, A Sadeghi Boroujeni, S Cao, S Tavakoli, R Ridolfo, ...
Pharmaceutics 13 (4), 445, 2021
272021
Effect of PEGylation on assembly morphology and cellular uptake of poly ethyleneimine-cholesterol conjugates for delivery of sorafenib tosylate in hepatocellular carcinoma
M Monajati, S Tavakoli, SS Abolmaali, G Yousefi, AM Tamaddon
BioImpacts: BI 8 (4), 241, 2018
232018
Liposomal sunitinib for ocular drug delivery: A potential treatment for choroidal neovascularization
S Tavakoli, J Puranen, S Bahrpeyma, VE Lautala, S Karumo, T Lajunen, ...
International Journal of Pharmaceutics 620, 121725, 2022
192022
Pharmacokinetics of pullulan–dexamethasone conjugates in retinal drug delivery
E Kicková, A Sadeghi, J Puranen, S Tavakoli, M Sen, VP Ranta, ...
Pharmaceutics 14 (1), 12, 2021
142021
Imaging, quantitation and kinetic modelling of intravitreal nanomaterials
A Sadeghi, M Ruponen, J Puranen, S Cao, R Ridolfo, S Tavakoli, ...
International Journal of Pharmaceutics 621, 121800, 2022
132022
Nucleic acid delivery to differentiated retinal pigment epithelial cells using cell-penetrating peptide as a carrier
B Subia, M Reinisalo, N Dey, S Tavakoli, A Subrizi, M Ganguli, ...
European Journal of Pharmaceutics and Biopharmaceutics 140, 91-99, 2019
132019
Microencapsulation of (deoxythymidine)20–DOTAP complexes in stealth liposomes optimized by Taguchi design
S Tavakoli, AM Tamaddon, N Golkar, SM Samani
Journal of Liposome Research 25 (1), 67-77, 2015
122015
Characterization, stability, and in vivo efficacy studies of recombinant human CNTF and its permeation into the neural retina in ex vivo organotypic retinal explant culture models
J Itkonen, A Annala, S Tavakoli, B Arango-Gonzalez, M Ueffing, ...
Pharmaceutics 12 (7), 611, 2020
82020
Design and synthesis of lipid-mimetic cationic iridium complexes and their liposomal formulation for in vitro and in vivo application in luminescent bioimaging
JR Shakirova, A Sadeghi, AA Koblova, PS Chelushkin, E Toropainen, ...
RSC advances 10 (24), 14431-14440, 2020
62020
Solid lipid microparticles of lamotrigine: an injectable controlled release system for local delivery in nerve injuries
S Mohammadi-Samani, F Jalali, S Tavakoli, F Ahmadi
Journal of Drug Delivery Science and Technology 24 (4), 367-372, 2014
32014
Intravitreal liposomes as ocular drug delivery systems: vitreal interactions, retinal permeation and drug release characteristics
S Tavakoli
Dissertationes Scholae Doctoralis Ad Sanitatem Investigandam Universitatis …, 2021
12021
Supplementary Materials: Characterization, Stability, and in Vivo Efficacy Studies of Recombinant Human CNTF and its Permeation into the Neural Retina in ex Vivo Organotypic …
J Itkonen, A Annala, S Tavakoli, B Arango-Gonzalez, M Ueffing, ...
The system can't perform the operation now. Try again later.
Articles 1–16